Allergy Therapeutics plc (AIM:AGY)

Allergy Therapeutics Revenue

In the fiscal year ending June 30, 2025, Allergy Therapeutics had annual revenue of 55.04M GBP, down -0.28%. Allergy Therapeutics had revenue of 21.01M in the half year ending June 30, 2025, with 6.75% growth.

• Revenue: 55.04M
• Revenue Growth: -0.28%
• P/S Ratio: 12.27
• Revenue / Employee: 94.25K
• Employees: 584
• Market Cap: 675.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	55.04M	-155.00K	-0.28%
Jun 30, 2024	55.20M	-4.39M	-7.36%
Jun 30, 2023	59.59M	-13.18M	-18.11%
Jun 30, 2022	72.77M	-11.56M	-13.71%
Jun 30, 2021	84.33M	6.13M	7.83%